Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.95
Price to sales ratio
-235.22

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4303
VERU
Veru Inc. - Common Stock
2.63 USD-4.01%-0.38%+19.00%+10.04%44.84 M USD
4304
GRCE
Grace Therapeutics, Inc. - Common Stock
2.12 USD-1.85%-4.93%+3.92%-46.73%44.60 M USD
4327
KPTI
Karyopharm Therapeutics Inc. - Common Stock
1.87 USD-3.61%-4.10%-73.21%-80.60%42.41 M USD
4344
MREO
Mereo BioPharma Group plc - American Depositary Shares
0.25 USD-7.41%-13.79%-21.88%-85.63%39.92 M USD

Frequently asked questions about Edesa Biotech, Inc. Common Shares

What is the Edesa Biotech, Inc. Common Shares stock price today?

The current price of Edesa Biotech, Inc. Common Shares (EDSA) is 4.62. Over the past 24 hours, the stock has changed by +0.43%. Follow the EDSA chart for real-time price dynamics.

What is the stock ticker of Edesa Biotech, Inc. Common Shares?

Edesa Biotech, Inc. Common Shares trades under the ticker EDSA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Edesa Biotech, Inc. Common Shares stock going up?

EDSA has changed by +3.82% over the last week, -12.67% over the last month, and +92.50% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Edesa Biotech, Inc. Common Shares?

Edesa Biotech, Inc. Common Shares currently has a market capitalization of 44.54 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Edesa Biotech, Inc. Common Shares earnings last quarter?

Last quarter, Edesa Biotech, Inc. Common Shares reported earnings of -0.6 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Edesa Biotech, Inc. Common Shares revenue for the last quarter?

Edesa Biotech, Inc. Common Shares reported quarterly revenue of 4 295. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Edesa Biotech, Inc. Common Shares net income for the last quarter?

Edesa Biotech, Inc. Common Shares reported net income of -5.41 M for the last quarter. The previous quarter showed -4.22 M, which means net income changed by -28.19%.

How many employees does Edesa Biotech, Inc. Common Shares have?

As of the latest available data, Edesa Biotech, Inc. Common Shares has 17 employees. Workforce size can provide additional context about the company's scale and operations.

What is Edesa Biotech, Inc. Common Shares EBITDA?

Edesa Biotech, Inc. Common Shares EBITDA is -1.56 M, and its EBITDA margin is -36.36 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Edesa Biotech, Inc. Common Shares stock?

You can buy Edesa Biotech, Inc. Common Shares (EDSA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Edesa Biotech, Inc. Common Shares stock?

Investing in Edesa Biotech, Inc. Common Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the EDSA chart and related analysis on metatrader.com as part of your research.

News